Clinical Trials Study
Copyright ©The Author(s) 2016.
World J Cardiol. Mar 26, 2016; 8(3): 283-292
Published online Mar 26, 2016. doi: 10.4330/wjc.v8.i3.283
Table 2 Summary of the primary and secondary outcomes at a minimum of 1-year follow-up period
VariableFFR < 0.75FFR > 0.75CDP > 27.9CDP < 27.9FFR < 0.80FFR > 0.80CDP < 25.4CDP > 25.4
Primary outcomeComposite of MACE
All-cause mortality3/202/662/353/514/351/513/472/39
Myocardial infarction1/201/660/352/512/350/511/471/39
Revascularization0/201/660/351/521/350/511/470/39
Secondary outcome: All questions related to patients’ condition after the procedureQ1: Health condition7/201/667/351/517/351/517/471/39
Q2: Heart attack0/200/660/350/510/350/510/470/39
Q3: Chest pain requiring medication6/206/667/355/516/356/517/475/39
Q4: Interventional procedure5/203/664/354/515/353/514/474/39
Q5: Re-hospitalization due to cardiac condition2/205/664/353/512/355/514/473/39